Adverum Biotechnologies Inc AVU0.BE
€3.74
Last Updated: Dec 09, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
AVU0.BE Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Adverum Biotechnologies Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Adverum Biotechnologies Inc. Stock Analysis AVU0.BE
Germany Health Care Micro Cap Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company is headquartered in Redwood City, California and currently employs 155 full-time employees. The company went IPO on 2014-07-31. The company discovers and develops gene therapy product candidates that provide durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration (wet AMD). Its other partnered programs include BGTF-027 (AAV.7m8-L-opsin), a gene therapy product candidate designed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy (BCM) via a single IVT injection.
Adverum Biotechnologies Inc (AVU0.BE) Chart
Financial Metrics & Statements of Adverum Biotechnologies Inc (AVU0.BE)
FAQ's for Adverum Biotechnologies Inc (AVU0.BE)
- As of August 2026, Adverum Biotechnologies Inc AVU0.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Adverum Biotechnologies Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Adverum Biotechnologies Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Adverum Biotechnologies Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Adverum Biotechnologies Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Adverum Biotechnologies Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Adverum Biotechnologies Inc (AVU0.BE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
